Safety and Efficacy of the BRAF Inhibitor Dabrafenib in Relapsed or Refractory Hairy Cell Leukemia: a Pilot Phase-2 Clinical Trial

Enrico Tiacci,Luca De Carolis,Edoardo Simonetti,Mara Merluzzi, Antonio Bennati,Vincenzo Maria Perriello,Alessandra Pucciarini,Alessia Santi,Alessandra Venanzi,Valentina Pettirossi,Gianluca Schiavoni,Luisa Tasselli,Stefano Ascani,Stefano Volpetti,Brunangelo Falini

Leukemia（2021）

引用 23|浏览14

关键词

Hairy cell leukaemia,Targeted therapies,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要